Join the Ian Burkhart Foundation for a night of Topgolf on Thursday, August 18, 2022, from 6 to 9 PM at Topgolf Columbus (Polaris). Funds raised at this event will support our equipment grants to provide tools for the independence of individuals with spinal cord injuries.
The U.S. healthcare market is in a continuous state of flux and uncertainty. Now more than ever, it’s imperative that pharmaceutical manufacturers partner with emerging vendors to overcome the unique market access challenges of rare disease and gene/cell therapies to avoid pitfalls and to drive a successful product launch. During this webinar, our experts will provide in-depth insights on commercialization strategy, distribution models and demonstrating therapeutic value of Rare Disease & Gene/Cell therapies for patients, payers, and providers. This event features member Michael Baldzicki, Chief Brand Officer, AscellaHealth.
On this edition of Founder's Story, Rev 1 Ventures will host a breakfast with DASI Simulations's team who performs advanced individualized computational predictive modeling powered by artificial intelligence and computer vision to better plan for improved patient outcomes and reduced costs associated with Structural Heart Disease.
A dramatic shift in regulatory opinions has occurred within the last several years regarding the concepts of Extractables and Leachables (E&L) testing of medical devices, commonly known as Chemical Characterization. Much of that change was driven by the 2020 revision to ISO 10993-18. Join NAMSA for this webinar to learn more about the foundations behind Chemical Characterization and to examine best practices deriving from it.
Grab your favorite drink (or just a drink), come learn and interact with industry experts while they discuss hot topics in Medtech. This session: Navigating the Complexities of the US Healthcare Reimbursement System
Once a year, the British-American Business Network brings together members of all 22 chapters throughout the US and UK at its Annual Transatlantic Business Conferences, for a 3-day program of high-level business discussions and networking with business executives actively involved in transatlantic business. Healthcare sessions on September 8th will features insightful speakers from OSU Wexner Medical Center, University Hospitals, Cleveland Clinic (USA/London, Eaton Corporation, BioOhio, and more.
Dayton’s biggest annual event for entrepreneurs and startup founders is fully back in person Sept. 13-15 at the Dayton Arcade and The Hub Powered by PNC.
The LifeTown Luncheon will feature Derrick Rossi, the co-founder of Moderna, as keynote speaker. Derrick is also currently the CEO of Ohio-based Convelo Therapeutics. The event, taking place from 11:30 am to 1 pm on Sept. 13 at the Greater Columbus Convention Center at 400 N. High St., raises money for LifeTown, which provides life skills for children with disabilities and other services, including a program to prevent substance abuse.
Please join us for an industry-wide briefing to discuss the importance of SBIR/STTR programs and the status of Congressional reauthorization. On September 13, AdvaMed Accel, SMTA, BIO, and CSBA will co-host a webinar to discuss the success of SBIR/STTR programs, the next steps to reauthorization, and Federal agencies' approach to a potential lapse in program authority.
MD+DI and Qmed present "Choosing a Medical Device Contract Manufacturer with the Right Quality and Regulatory Credentials." Join Spartronics Site Leaders Casey Cramer, and Ryan Carlson, on Thursday, September 15th at 2:00 PM ET for a live webinar hosted by industry leader MD+DI. The two will discuss the importance of selecting a medical contract manufacturer with the right quality and regulatory credentials to support the manufacturing of medical devices. As Site Leaders of focused medical facilities, they’ll touch upon the various quality and regulatory credentials for electronic and electromechanical medical devices. Additionally, they’ll dive into the value of the Medical Device Single Audit Program (MDSAP) and its impact on medical device contract manufacturing.